Oncternal Therapeutics, Inc. (NASDAQ:ONCT)

About the company

Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. It focuses on drug development of untapped biological pathways implicated in cancer progression. The company was founded by David F. Hale and James B. Breitmeyer in 1997 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

14

$3.00M

Total Revenue

14

Employees

$36.92M

Market Capitalization

-1.46

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$3M

Operating Margin (in %)

Total operating margin

$-7M

Net Margin (in %)

Total net margin

$-7M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 371915.59 82729.00 5.98 21.67 20.75
Merck & Co., Inc. MRK 198428.78 48081.00 7.45 19.58 21.10
Pfizer Inc. PFE 184460.70 50660.00 2.79 11.68 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110955.81 31006.00 2.69 94.33 3.08
Repligen Corp. RGEN 6333.69 286.00 6.07 275.98 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 3945.92 137.00 3.08 -8.59 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3604.64 1.00 33.33 -5.51 None
Allakos, Inc. ALLK 3339.11 None 7.25 -35.70 None
Karuna Therapeutics, Inc. KRTX 2897.96 None 7.57 -71.45 None
ADC Therapeutics SA ADCT 2527.74 2.00 29.82 -21.67 None
Turning Point Therapeutics, Inc. TPTX 2310.84 None 6.95 -19.33 None
IGM Biosciences, Inc. IGMS 2263.00 None 9.97 -41.71 None
Apellis Pharmaceuticals, Inc. APLS 2155.56 None 9.52 -5.17 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
OPKO Health, Inc. OPK 2076.69 891.00 1.48 -7.10 -32.92
Springworks Therapeutics, Inc. SWTX 1779.34 None 5.78 -28.54 None
Principia Biopharma, Inc. PRNB 1575.84 30.00 5.61 -22.42 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1556.96 None 9.54 -16.90 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Kiniksa Pharmaceuticals Ltd. KNSA 1401.40 None 7.26 -11.58 None
Akcea Therapeutics, Inc. AKCA 1348.30 341.00 2.77 -47.93 -8.59
Tricida, Inc. TCDA 1312.71 None 6.75 -6.22 None
Odonate Therapeutics, Inc. ODT 1233.37 None 10.10 -10.96 None
Arcutis Biotherapeutics, Inc. ARQT 1221.37 None 5.21 -19.53 None
Athenex, Inc. ATNX 1073.28 123.00 6.58 -9.97 -87.86
Phibro Animal Health Corp. PAHC 1050.83 818.00 5.31 28.48 4.49
Oric Pharmaceuticals, Inc. ORIC 957.32 None -10.39 -31.66 None
Constellation Pharmaceuticals, Inc. CNST 906.56 None 3.77 -9.77 None
G1 Therapeutics, Inc. GTHX 902.50 1.00 3.91 -6.88 None
Phathom Pharmaceuticals, Inc. PHAT 822.75 None 4.56 -3.02 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Applied Therapeutics, Inc. APLT 795.30 None 5.13 -16.14 None
Gossamer Bio, Inc. GOSS 793.00 None 3.22 -3.99 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Krystal Biotech, Inc. KRYS 702.10 None 4.09 -33.85 None
Akero Therapeutics, Inc. AKRO 681.50 None 5.69 -13.43 None
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 635.68 1679.00 4.38 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 610.74 19.00 56.60 -21.95 -151.34
Oyster Point Pharma, Inc. OYST 606.48 None 6.09 -10.54 None
SIGA Technologies, Inc. SIGA 503.48 19.00 5.63 -25.58 -94.00
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 469.71 None 4.54 -13.35 None
DURECT Corp. DRRX 465.00 28.00 35.71 -19.23 -82.94
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
Crinetics Pharmaceuticals, Inc. CRNX 429.12 1.00 5.42 -7.36 -447.78
Fulcrum Therapeutics, Inc. FULC 420.67 1.00 7.09 -6.10 None
Relmada Therapeutics, Inc. RLMD 402.75 0.00 6.01 -33.65 -877.66
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
Kala Pharmaceuticals, Inc. KALA 383.40 6.00 4.19 -4.18 None
TCR2 Therapeutics, Inc. TCRR 374.16 None 2.56 -37.12 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 331.65 None 7.84 -5.08 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 307.89 4.00 9.72 -3.84 -523.27
HOOKIPA Pharma, Inc. HOOK 302.12 13.00 2.73 -6.68 -333.02
89bio, Inc. ETNB 297.09 None 3.67 -4.60 None
IDEAYA Biosciences, Inc. IDYA 284.20 None 4.32 -6.52 None
AMAG Pharmaceuticals, Inc. AMAG 280.33 321.00 1.07 -0.76 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 254.00 None 4.64 -8.33 None
Spero Therapeutics, Inc. SPRO 251.75 12.00 3.31 -3.10 -656.72
Gritstone Oncology, Inc. GRTS 235.80 4.00 2.11 -2.26 None
Kaleido Biosciences, Inc. KLDO 228.00 None 8.09 -3.11 None
KalVista Pharmaceuticals, Inc. KALV 218.16 12.00 2.41 -6.73 -263.38
Veru, Inc. VERU 218.08 39.00 7.29 -22.37 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Liquidia Technologies, Inc. LQDA 182.16 8.00 10.75 -3.70 -602.17
Galera Therapeutics, Inc. GRTX 180.50 None 3.37 -2.75 None
Sutro Biopharma, Inc. STRO 174.22 41.00 3.31 -2.86 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 168.00 532.00 30.88 -11.54 26.69
Evelo Biosciences, Inc. EVLO 165.12 None 4.23 -1.88 None
Evolus, Inc. EOLS 162.00 45.00 2.90 -1.60 -217.51
Cyclerion Therapeutics, Inc. CYCN 159.57 6.00 2.01 -1.54 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
scPharmaceuticals, Inc. SCPH 140.50 119.00 3.59 -4.48 -27.05
Aquestive Therapeutics, Inc. AQST 136.08 49.00 -7.84 -1.94 -139.64
Harrow Health, Inc. HROW 135.46 51.00 8.68 -5.48 -47.54
Lyra Therapeutics, Inc. LYRA 135.12 1.00 -1.15 -8.10 -491.16
PhaseBio Pharmaceuticals, Inc. PHAS 133.40 2.00 2.47 -2.79 None
Trevi Therapeutics, Inc. TRVI 125.82 None 2.67 -4.29 None
Mustang Bio, Inc. MBIO 125.80 None 2.94 -2.56 None
NeuBase Therapeutics, Inc. NBSE 122.92 None 51.65 -2.75 None
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
TFF Pharmaceuticals, Inc. TFFP 109.44 None 4.24 -2.82 None
Eton Pharmaceuticals, Inc. ETON 109.08 1.00 11.88 -5.46 None
Milestone Pharmaceuticals, Inc. MIST 94.25 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 82.84 26.00 5.85 -1.69 -196.30
Clearside Biomedical, Inc. CLSD 82.00 6.00 10.53 -4.65 -293.61
Corvus Pharmaceuticals, Inc. CRVS 78.01 None 1.25 -1.65 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 76.44 4.00 3.79 -0.59 None
Baudax Bio, Inc. BXRX 74.70 None -2.03 -1.06 None
Navidea Biopharmaceuticals, Inc. NAVB 69.19 1.00 -50.88 -6.26 -65.13
Aridis Pharmaceuticals, Inc. ARDS 59.67 1.00 -24.56 -2.04 -851.00
Genprex, Inc. GNPX 59.66 None 5.06 -4.36 None
BiomX, Inc. PHGE 59.51 None 1.57 -1.39 None
Assertio Therapeutics, Inc. ASRT 59.47 192.00 1.03 -0.36 -83.99
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Moleculin Biotech, Inc. MBRX 44.35 None 3.86 -4.82 None
Edesa Biotech, Inc. EDSA 44.19 0.00 6.29 -0.46 -395.23
AgeX Therapeutics, Inc. AGE 38.00 2.00 -50.00 -3.12 -658.11
Oncternal Therapeutics, Inc. ONCT 36.92 3.00 4.73 -1.46 -225.89
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Acer Therapeutics, Inc. ACER 33.88 3.00 2.47 -1.30 -274.69
CNS Pharmaceuticals, Inc. CNSP 33.44 None 5.81 -6.15 None
Aileron Therapeutics, Inc. ALRN 31.64 None 4.35 -1.19 None
Adamis Pharmaceuticals Corp. ADMP 31.32 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.52 None 2.79 -24.22 None
Mannatech, Inc. MTEX 30.32 156.00 1.28 6.83 3.45
Citius Pharmaceuticals, Inc. CTXR 29.70 None 2.20 -1.72 None
Millendo Therapeutics, Inc. MLND 27.15 0.00 0.64 -0.58 None
Hoth Therapeutics, Inc. HOTH 25.30 None 7.03 -2.81 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.52 0.00 0.89 -0.90 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.79 1.00 8.24 -1.12 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 14.20 None 3.46 -1.87 None
PDS Biotechnology Corp. PDSB 14.07 None 1.56 -0.55 None
Novan, Inc. NOVN 14.01 5.00 -3.22 -0.44 -602.34
Titan Pharmaceuticals, Inc. TTNP 11.80 4.00 4.92 -0.66 -437.91
Novus Therapeutics, Inc. NVUS 7.30 None 0.62 -0.35 None
Brickell Biotech, Inc. BBI 5.00 5.00 1.64 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Oncternal Therapeutics Announces Increased Focus Of Antibody Program On Mantle Cell Lymphoma

1d ago, source: Reuters

ONCTERNAL THERAPEUTICS ANNOUNCES INCREASED FOCUS OF THE CIRMTUZUMAB ROR1 ANTIBODY PROGRAM ON MANTLE CELL LYMPHOMA * ONCTERNAL THE ...

Oncternal Therapeutics Announces Orphan Drug Designations of Cirmtuzumab ROR1 Antibody for Treatment of Mantle Cell Lymphoma and for Treatment of Chronic Lymphocytic Leukemia

1d ago, source: Business Wire

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today ...

Oncternal Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Business Update

4d ago, source: YAHOO!

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report its fourth ...

Oncternal wins dismissal of shareholder lawsuit over GTx merger

8d ago, source: Reuters

Biotechnology company Oncternal Therapeutics, which specializes in cancer treatments, has won dismissal of a lawsuit by shareholders who said they were shortchanged by the company's merger with GTx ...

Shareholder Suit Over GTx And Oncternal Merger Tossed

8d ago, source: Law360

A New York federal judge on Tuesday dismissed a proposed class action filed against merged biopharmaceutical companies GTx Inc. and Oncternal Therapeutics Inc. that alleged they misrepresented the ...

Oncternal Therapeutics Inc.

14d ago, source: MarketWatch

02/14/2020 N/A SC 13G/A Institutional Ownership * 02/14/2019 N/A SC 13G/A Institutional Ownership * 02/14/2019 N/A SC 13G/A Institutional Ownership * 02/14/2019 N/A ...

Otonomy Inc.

12d ago, source: MarketWatch

Founder of Zogenix, Inc. and Oncternal Therapeutics, Inc., James B. Breitmeyer is an American businessperson who has been at the head of 5 different companies and currently occupies the position ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.